Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-185-5 | CAS number: 1310-73-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- other: review of articles
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Original references are not available
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Recommendations on dietary salt
- Author:
- Fodor, J.G.
- Year:
- 1 999
- Bibliographic source:
- CMAJ, May 4, 1999; 160 (9 Suppl), page S29-S34
Materials and methods
- Objective of study:
- other: evidence-based recommendations concerning effects of dietary salt intake on prevention and control of hypertension in adults (except pregnant women)
- Principles of method if other than guideline:
- A MEDLINE search was conducted for the period 1966-1996 using the terms hypertension, blood pressure, vascular resistance, sodium chloride, sodium, diet, sodium or sodium chloride dietary, sodium restricted/reducing diet, clinical trials, controlled clinical trial, randomized controlled trial and random allocation. Both trials and review articles were obtained, and other revelant evidence was obtained from the reference lists of the articles identified, from the personal files of the autors and through contacts with experts. The articles were reviewed, classified according to study design and graded according to level of evidence. In addition, a systematic review of all published randomized controlled trials relating to dietary salt intake and hypertension was conducted
- GLP compliance:
- no
Test material
- Reference substance name:
- Sodium
- EC Number:
- 231-132-9
- EC Name:
- Sodium
- Cas Number:
- 7440-23-5
- IUPAC Name:
- sodium
- Details on test material:
- - Name of test material (as cited in study report): sodium
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- human
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- STUDY SUBJECTS:
- Age at study initiation (in articles reviewed): subjects in the studies of normotensive people were generally younger (mean age 26 years) than those in the studies of hypertensive people (mean age 47 years)
- Diet: dietary salt intake was studied in the articles reviewed
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- not specified
- Duration and frequency of treatment / exposure:
- Studies of normotensive subjects tended to be short-term studies with less than 1 month of intervention. Only 3 long-term studies of normotensive subjects (lasting more than 1 year) were identified. Trials with hypertensive subjects had longer intervention periods, and 5 long-term studies were identified.
- No. of animals per sex per dose / concentration:
- number of subjects not specified.
- Control animals:
- other: normotensive population
- Statistics:
- A statistical analysis was performed to determine the effect of dietary interventions by correlating changes in urinary excretion of sodium with changes in blood pressure.
Results and discussion
Any other information on results incl. tables
Twenty-nine studies of normotensive subjects and 30 studies of hypertensive subjects were identified and reviewed. Studies of normotensive subjects tended to be shortterm studies with less than 1 month of intervention. Only 3 long-term studies of normotensive subjects (lasting more than 1 year) were identified. The subjects in the studies of normotensive people were generally younger (mean age 26 years) than those in the studies of hypertensive people (mean age 47 years). Trials with hypertensive subjects had longer intervention periods, and 5 long-term studies were identified. Apart from the meta-analysis, 19 additional studies were evaluated.
-Restriction of salt intake for normotensive people is not recommended at present because of insufficient evidence of hypertension (grade B recommendation)
-To avoid excessive intake of salt people should be counselled to choose foods low in salt (e.g., pre-prepared foods), to refrain from adding salt at the table and minimize the amount of salt used in cooking, and to increase their awareness of the salt content of food choices in restaurants (grade D recommendations)
-It is recommended that the salt consumption of hypertensive patients be determined by interview (grade D recommendation)
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.